Imphal: Ayush-64, a polyherbal formulation, which can be used for Covid-19 patient treatment, was launched at the chief minister’s secretariat on Friday.
“The use of Ayush-64 (tablet) had been approved by the ministry of Ayush, for use by adults (above 18 years of age) in treatment of Covid-19,” chief minister N. Biren Singh said as he launched the medicine.
The tablet had been approved after proper clinical trials, he said.
“It would be useful in treating asymptomatic, mild and moderate Covid-19 patients as the same is purely organic and will not have any side effects,” Biren said.
Union minister of state for Ayush (Iidependent charge) Kiren Rijiju launched Ayush-64 on May7 for nationwide distribution campaign for benefit of the vast majority of out-of-hospital Covid-19 patients.
The ministry in collaboration with Council of Scientific and Industrial Research had also recently completed a robust Multi Centre Clinical Trial to evaluate the safety and efficacy of Ayush-64 in the management of mild to moderate Covid-19 patients. It was found that the medicine reduces the duration for clinical recovery in terms of diseases, symptoms and severity.